infacare.com

Infacare Pharmaceutical Corporation

INFACARE IS NOW PART OF MALLINCKRODT PHARMACEUTICALS. InfaCare is now part of Mallinckrodt Pharmaceuticals. Lead product, stannsoporfin, is currently in development as a pharmacologic treatment for neonatal jaundice, known clinically as hyperbilirubinemia HB . At present the final phase IIB clinical study of stannsoporfin in neonates has been completed, the Jasmine trial. Mallinckrodt has global rights to stannsoporfin, including an extensive patent estate. Emergency Use of Stannsoporfin.
history traffic contact

OVERVIEW

The site infacare.com currently has a traffic classification of zero (the smaller the more users). We have parsed eight pages within the domain infacare.com and found eleven websites referring to infacare.com. We were able to find one contacts and locations for infacare.com to help you correspond with them. The site infacare.com has been on the internet for one thousand and ninety-six weeks, four days, eleven hours, and thirty-one minutes.
Pages Parsed
8
Links to this site
11
Contacts
1
Addresses
1
Online Since
Jul 2003

INFACARE.COM TRAFFIC

The site infacare.com has seen variant amounts of traffic in the past the year.
Traffic for infacare.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for infacare.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for infacare.com

Date Range

All time
This Year
Last Year
Last Month

INFACARE.COM HISTORY

The site infacare.com was began on on July 04, 2003. This web page will go back on the market on the date of June 20, 2015. As of today, it is one thousand and ninety-six weeks, four days, eleven hours, and thirty-one minutes young.
REGISTERED
July
2003
EXPIRED
June
2015

DOMAIN PERIOD

21
YEARS
0
MONTHS
4
DAYS

LINKS TO INFACARE.COM

Longitude Capital Venture Growth Investing in Life Sciences

We invest in both privately held and publicly traded life science companies through a variety of investment approaches. 2 billion across three funds and demonstrated an ability to source, manage and exit attractive investments across multi.

WHAT DOES INFACARE.COM LOOK LIKE?

Desktop Screenshot of infacare.com Mobile Screenshot of infacare.com Tablet Screenshot of infacare.com

CONTACTS

InfaCare Pharmaceutical Corp

Ron Goldfuss

8 Neshaminy Interplex Suite 221

Trevose, Pennsylvania, 19053

United States

1.2675155857
rgoldfuss@infacare.com

INFACARE.COM SERVER

We identified that a lone root page on infacare.com took one thousand two hundred and sixty-seven milliseconds to stream. We could not discover a SSL certificate, so therefore our parsers consider infacare.com not secure.
Load time
1.267 sec
SSL
NOT SECURE
IP
206.188.193.81

NAME SERVERS

ns71.domaincontrol.com
ns72.domaincontrol.com

WEBSITE ICON

SERVER SOFTWARE

We detected that this domain is operating the openresty/1.11.2.4 operating system.

SITE TITLE

Infacare Pharmaceutical Corporation

DESCRIPTION

INFACARE IS NOW PART OF MALLINCKRODT PHARMACEUTICALS. InfaCare is now part of Mallinckrodt Pharmaceuticals. Lead product, stannsoporfin, is currently in development as a pharmacologic treatment for neonatal jaundice, known clinically as hyperbilirubinemia HB . At present the final phase IIB clinical study of stannsoporfin in neonates has been completed, the Jasmine trial. Mallinckrodt has global rights to stannsoporfin, including an extensive patent estate. Emergency Use of Stannsoporfin.

PARSED CONTENT

The site infacare.com had the following in the site, "INFACARE IS NOW PART OF MALLINCKRODT PHARMACEUTICALS." I noticed that the webpage stated " InfaCare is now part of Mallinckrodt Pharmaceuticals." They also stated " Lead product, stannsoporfin, is currently in development as a pharmacologic treatment for neonatal jaundice, known clinically as hyperbilirubinemia HB . At present the final phase IIB clinical study of stannsoporfin in neonates has been completed, the Jasmine trial. Mallinckrodt has global rights to stannsoporfin, including an extensive patent estate."

SEE MORE DOMAINS

INFACE Danish eyewear design since 1987

Our style is contemporary and casual, with clear references to minimalistic and functional traditions of Danish Design. When designing, we use proven technologies of the eyewear industry and combine it with colors and shapes from the fashion industry. This way we create designs, which are both on trend and surprisingly affordable. Inface is great design, made accessible to everyone.

INFACES Imerso nos sonhos, em algum lugar do mundo.

Imerso nos sonhos, em algum lugar do mundo. Olhos puxados, perfeccionista, geminiano, rumo aos trinta. Insano surreal, facilmente complicado, constantemente inconstante, dependente químico de capuccino e trabalho, cheio de qualidades, defeitos, conflitos e neuras. Seja um cumplice, leia e faça-me parte de sua vida. E se puder, deixe a sua marca. Crie um website ou blog gratuito no WordPress.

In Face Value By Make-up Artist Ashley Vaughn Soria

By Make-up Artist Ashley Vaughn Soria. This product is not for everyone.

iNFacilities -Home

Welkom op de portal van iNFacilities. Via de portal van iNFacilities bieden wij onze medewerkers en opdrachtgevers volop digitaal gemak. We zijn continu bezig om onze dienstverlening via internet verder te ontwikkelen. Aan uitbreiding van de mogelijkheden op de portal wordt dan ook veel aandacht besteed. Indien er iets niet helemaal in orde is, neem dan contact op met uw leidinggevende. Voor de urenregistratie raadplegen! Kantoor Amsterdam Asterweg 19 D6 1031 HL 020-8203451 meer contactgegevens.

InfaCitys Top 100 Sites List

Handcrafted for style hand wired for strength. Handmade cloth dolls, unique, one-of-a-kind, made safe and durable for even the most active child with many styles to choose from. Entertainment Brand and Product Marketing. We got what you need! .